Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide"...Konipineni S, Valecha J, Meme CD, et al. Am J Cardiovasc Drugs 26, 507–509 (2026).

This letter addresses the use of trial sequential analysis (TSA) in evaluating colchicine for secondary prevention of cardiovascular disease (CVD), responding to comments by Konipineni et al. The authors acknowledge TSA’s benefits but highlight its limitations, including sensitivity to assumptions a...

Full description

Bibliographic Details

Published in:	American Journal of Cardiovascular Drugs Vol. 26; no. 4; pp. 511 - 513
Main Authors:	Li, Hoi-Ying, Cheriyan, Joseph, Chan, Tsz-Kwan, Yiu, Kai-Hang, Tse, Hung-Fat, Wilkinson, Ian B., Chan, Yap-Hang
Format:	letter response Journal Article
Published:	Springer Nature Jul2026
Online Access:	View this record in EBSCOhost